Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 7 Affordable and Clean Energy -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of a novel multi-engager antibody complex to augment natural killer cell function and durability in lymphoma
Walcheck, B. (PI), Bachanova, V. (CoI), Felices, M. (CoI) & Rendahl, A. (CoI)
8/15/25 → 8/14/27
Project: Research project
-
Enhancing long-term persistence of CAR-NK cells for treatment of solid tumors
Kennedy, P. (PI), Provenzano, P. (PI), Subramanian, S. (PI), Felices, M. (CoI), Kumar, A. (CoI) & Miller, J. S. (CoI)
7/1/25 → 6/30/27
Project: Research project
-
Evaluation of Novel TriKE-PACC Molecule to Amplify Natural Killer Cell Function in Mesothelioma
Felices, M. (PI), Patel, M. R. (PI), Walcheck, B. (PI), Kratzke, R. A. (CoI) & Miller, J. S. (CoI)
7/15/24 → 7/14/26
Project: Research project
-
Trapping Inhibitory Signals in Synergy with Cytokine Signaling to Maximize NK Cell Immunotherapy in Ovarian Cancer
Felices, M. (PI) & Miller, J. S. (CoI)
7/1/24 → 6/30/28
Project: Research project
-
Leveraging Targeted Biological Complexes to Maximize Natural Killer Cell Immunotherapy in Lung Cancer
Felices, M. (PI), Kratzke, R. A. (PI), Fujioka, N. (CoI) & Miller, J. S. (CoI)
7/1/24 → 6/30/27
Project: Research project
-
A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer
Sheedy, A. M., Shetty, M., Weis, A., Bendzick, L. E., Stenger, T., Ni, Z., Kennedy, P. R., Myers, J. A., Ward, N., Trask, L., Prendeville, H., O’Dwyer, J., O’Dwyer, M., Roche, E. T., Duffy, G. P., Miller, J. S., Geller, M. A., Dolan, E. B. & Felices, M., Mar 20 2026, In: Device. 4, 3, 101050.Research output: Contribution to journal › Article › peer-review
Open Access -
Can natural killer cells cure leukemia?
Cichocki, F. M., Felices, M., Matson, A. W., Lee, M. J. & Miller, J. S., 2026, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dual-functioning Targeted ADAM17 Blocker CD16 (TAB16) mediates selective ADAM17 inhibition in NK cells and engages overexpressed ADAM17 in tumor cells to induce cytotoxicity
Dixon, K. J., Hullsiek, R., Wang, S., Friess, R. R., Matson, A. W., Soignier, Y., Lenvik, A. J., Wu, J., Hart, G. T., Felices, M. & Walcheck, B., 2026, In: Frontiers in immunology. 17, 1714022.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer
Likasitwatanakul, P., Besonen, C., Tsai, A. K., Sadeghipour, N., Elliott, A., Arafa, A. T., Passow, R., Chesner, L., Felices, M., Kennedy, P. R., Patnaik, A., Narayan, V., Hamrick, J., Sena, L. A., Zorko, N. A., Hwang, J. H. & Antonarakis, E. S., Jun 2026, In: Prostate Cancer and Prostatic Diseases. 29, 2, p. 425-434 10 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Reprogramming endogenous NK circuits by highly efficient nonviral genome editing
Huang, R. S., Phung, S. K., Sumstad, D., Weis, A. J., Kile, Q. M., Bendzick, L., Khaw, M. J., Vue, Y. Y., McKenna, D. H., Kennedy, P. R., Miller, J. S. & Felices, M., Jul 6 2026, In: The Journal of experimental medicine. 223, 7Research output: Contribution to journal › Article › peer-review